The genetics of the human APOE polymorphism

Rejuvenation Research

Volumn 14, Issue 5, 2011, Pages 491-500

  Seripa, Davide ^a   D'Onofrio, Grazia ^a   Panza, Francesco ^a   Cascavilla, Leandro ^a   Masullo, Carlo ^b   Pilotto, Alberto ^a,c  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c S ANTONIO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN B RECEPTOR; APOLIPOPROTEIN E; APOLIPOPROTEIN E RECEPTOR; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E3R; APOLIPOPROTEIN E4; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RECEPTOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AFRICAN AMERICAN; AGING; ALLELE; ALZHEIMER DISEASE; AUTISM; CAUCASIAN; CHROMOSOME 19Q; CODON; CONFERENCE PAPER; DNA POLYMORPHISM; GENE LOCUS; GENE MUTATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; LONGEVITY; MOLECULAR EVOLUTION; MOLECULAR MODEL; MOTOR NEURON DISEASE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN VARIANT; RECEPTOR BINDING; SINGLE NUCLEOTIDE POLYMORPHISM;

APOLIPOPROTEINS E; EVOLUTION, MOLECULAR; FAMILY; HAPLOTYPES; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS;

EID: 80055007462     PISSN: 15491684     EISSN: 15578577     Source Type: Journal    
DOI: 10.1089/rej.2011.1169     Document Type: Conference Paper

References (47)

1. Nickerson DA, Taylor SL, Fullerton SM,Weiss KM, Clark AG, Stengard JH, Salomaa V, Boerwinkle E, Sing CF. Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene. Genome Res 2000;10:1532-1545.
2. Siest G, Pillot T, Regis-Bailly A, Leininger-Muller B, Steinmetz J, Galteau MM, Visvikis S. Apolipoprotein E: An important gene and protein to follow in laboratory medicine. Clin Chem 1995;41:1068-1086.
3. Seripa D, Franceschi M, Matera MG, Panza F, Kehoe PG, Gravina C, Orsitto G, Solfrizzi V, Di Minno G, Dallapiccola B, Pilotto A. Sex differences in the association of apolipoprotein E and angiotensin-converting enzyme gene polymorphisms with healthy aging and longevity: a populationbased study from Southern Italy. J Gerontol A Biol Sci Med Sci 2006;61:918-923. (Pubitemid 44413930)
4. Seripa D, Panza F, Franceschi M, D'Onofrio G, Solfrizzi V, Dallapiccola B, Pilotto A. Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease. Ageing Res Rev 2009;8:214-236.
5. Shore B, Shore V. Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components. Biochemistry 1973;12:502-507.
6. Utermann G, Jaeschke M, Mangel J. Familial hyperlipoproteinemia type III: deficiency of a specific apolipoprotein (apo E-III) in the very-low-density lipoproteins. FEBS Lett 1975;56:352-355.
7. Utermann G, Canzler H, Hees M, Jaeschke M, Mü hlfellner G, Schoenborn W, Vogelberg KH. Studies on the metabolic defect in broad-beta disease (hyperlipoproteinaemia type III). Clin Genet 1977;12:139-154. (Pubitemid 8208183)
8. Utermann G, Hees M, Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in man. Nature 1977;269:604-607.
9. Pagnan A, Havel RJ, Kane JP, Kotite L. Characterization of human very low density lipoproteins containing two electrophoretic populations: Souble pre-beta lipoproteinemia and primary dysbetalipoproteinemia. J Lipid Res 1977;18:613-622. (Pubitemid 8197566)
10. Marcel YL, Bergseth M, Nestruck AC. Preparative isoelectric focusing of apolipoproteins C and E from human very low density lipoproteins. Biochim Biophys Acta 1979;573:175-183. (Pubitemid 9156939)
11. Warnick GR, Mayfield C, Albers JJ, Hazzard WR. Gel focusing method for specific diagnosis of familial hyperlipoproteinemia type 3. Clin Chem 1979;25:279-284. (Pubitemid 9142909)
12. Weidman SW, Suarez B, Falko JM, Witztum JL, Kolar J, Raben M, Schonfeld G. Type III hyperlipoproteinemia: Development of a VLDL ApoE gel isoelectric focusing technique and application in family studies. J Lab Clin Med 1979;93:549-569. (Pubitemid 10210581)
13. Zannis VI, Breslow JL. Characterization of a unique human apo E variant associated with type III hyperlipoproteinemia. J Biol Chem 1980;255:1759-1762. (Pubitemid 10114801)
14. Zannis VI, Just PW, Breslow JL. Human apolipoprotein E isoprotein subclasses are genetically determined. Am J Hum Genet 1981;33:11-24. (Pubitemid 11188459)
15. Zannis VI, Breslow JL, Utermann G, Mahley RW, Weisgraber KH, Havel RJ, Goldstein JL, Brown MS, Schonfeld G, Hazzard WR, Blum C. Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. J Lipid Res 1982;23:911-914. (Pubitemid 13244364)
16. Breslow JL, McPherson J, Nussbaum AL, Williams HW, Lofquist-Kahl F, Karathanasis SK, Zannis VI. Identification and DNA sequence of a human apolipoprotein E cDNA clone. J Biol Chem 1982;257;14639-41461.
17. Das HK, McPherson J, Bruns GA, Karathanasis SK, Breslow JL. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. J Biol Chem 1985;260:6240-6247. (Pubitemid 15071325)
18. Paik YK, Chang DJ, Reardon CA, Davies GE, Mahley RW, Taylor JM. Nucleotide sequence and structure of the human apolipoprotein E gene. Proc Natl Acad Sci USA 1985;82:3445-3449. (Pubitemid 15030700)
19. EmiM,Wu LL, RobertsonMA, Myers RL, Hegele RA,Williams RR,White R, Lalouel JM. Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics 1988;3:373-379.
20. Seripa D, Matera MG, Daniele A, Bizzarro A, Rinaldi M, Gravina C, Bisceglia L, Corbo RM, Panza F, Solfrizzi V, Fazio VM, Forno GD, Masullo C, Dallapiccola B, Pilotto A. The missing ApoE allele. Ann Hum Genet 2007;71:496-500. (Pubitemid 46865497)
21. Persico AM, D'Agruma L, Zelante L, Militerni R, Bravaccio C, Schneider C,Melmed R, Trillo S,Montecchi F, EliaM, Palermo M, Rabinowitz D, Pascucci T, Puglisi-Allegra S, Reichelt KL, Muscarella L, Guarnieri V,Melgari JM, ConciatoriM, Keller F. Enhanced APOE2 transmission rates in families with autistic probands. Psychiatr Genet 2004;14:73-82. (Pubitemid 38766413)
22. Murrell JR, Price BM, Baiyewu O, Gureje O, Deeg M, Hendrie H, Ogunniyi A, Hall K. The fourth apolipoprotein E haplotype found in the Yoruba of Ibadan. Am J Med Genet B Neuropsychiatr Genet 2006;141B:426-427. (Pubitemid 43872898)
23. http://browser.1000genomes.org
24. Hendrie HC, Ogunniyi A, Hall KS, Baiyewu O, Unverzagt FW, Gureje O, Gao S, Evans RM, Ogunseyinde AO, Adeyinka AO, Musick B, Hui SL. Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA 2001;285:739-747. (Pubitemid 32167232)
25. al-Chalabi A, Enayat ZE, Bakker MC, Sham PC, Ball DM, Shaw CE, Lloyd CM, Powell JF, Leigh PN. Association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease. Lancet 1996;347:159-160. (Pubitemid 26025156)
26. Matera MG, Sancarlo D, Panza F, Gravina C, D'Onofrio G, Frisardi V, Longo G, D'Ambrosio LP, Addante F, Copetti M, Solfrizzi V, Seripa D, Pilotto A. Apolipoprotein E-related allcause mortality in hospitalized elderly patients. Age (Dordr) 2010;32:411-420.
27. Seripa D, Signori E, Gravina C, Matera MG, Rinaldi M, Fazio VM. Simple and effective determination of apolipoprotein E genotypes by positive/negative polymerase chain reaction products. Diagn Mol Path 2006;15:180-185. (Pubitemid 44325481)
28. Iurescia S, Fioretti D, Mangialasche F, Rinaldi M. The pathological cross talk between apolipoprotein E and amyloidbeta peptide in Alzheimer's disease: Emerging gene-based therapeutic approaches. J Alzheimers Dis 2010;21:35-48.
29. Hanlon CS, Rubinsztein DC. Arginine residues at codons 112 and 158 in the apolipoprotein E gene correspond to the ancestral state in humans. Atherosclerosis 1995;112:85-90.
30. Finch CE, Sapolsky RM. The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms. Neurobiol Aging 1999;20:407-428.
31. Mahley RW, Rall SC Jr. Is epsilon 4 the ancestral human apoE allele? Neurobiol Aging 1999;20:429-430.
32. Panza F, D'Introno A, Colacicco AM, Capurso C, Capurso S, Kehoe PG, Capurso A, Solfrizzi V. Vascular genetic factors and human longevity. Mech Ageing Dev 2004;125, 169-178. (Pubitemid 38317272)
33. Corbo RM, Scacchi R. Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a 'thrifty' allele? Ann Hum Genet 1999;63:301-310. (Pubitemid 30021229)
34. Aleshkov SB, Li X, Lavrentiadou SN, Zannis VI. Contribution of cysteine 158, the glycosylation site threonine 194, the amino-and carboxy-terminal domains of apolipoprotein E in the binding to amyloid peptide beta (1-40). Biochemistry 1999;38:8918-8925.
35. Role of apoE in Lipoprotein Metabolism and Type III HLP. Accessed at http://www.gladstone.ucsf.edu/gladstone/site/Mahley/content/1/70, February 2, 2011.
36. Louhija J, Viitanen M, Aguero-Torres H, Tilvis R. Survival in Finnish centenarians in relation to apolipoprotein E polymorphism. J Am Geriatr Soc 2001;49:1007-1008. (Pubitemid 32743646)
37. Tilvis RS, Strandberg TE, Juva K. Apoliprotein E phenotypes, dementia and mortality in a prospective population sample. J Am Geriatr Soc 1998;46:712-715. (Pubitemid 28262346)
38. Ewbank DC. Differences in the association between apolipoprotein E genotype and mortality across populations. J Gerontol A Biol Sci Med Sci 2007;62:899-907. (Pubitemid 350131676)
39. Dal Forno G, Carson KA, Brookmeyer R, Troncoso J, Kawas CH, Brandt J. APOE genotype and survival in men and women with Alzheimer's disease. Neurology 2002;58:1045-1050. (Pubitemid 34298543)
40. Rosvall L, Rizzuto D, Wang HX,Winblad B, Graff C, Fratiglioni L. APOE-related mortality: Effect of dementia, cardiovascular disease and gender. Neurobiol Aging 2009;30:1545-1551.
41. Rockwood K, Nassar B, Mitnitski A. Apolipoprotein Epolymorphism, frailty and mortality in older adults. J Cell Mol Med 2008;12:2754-2761.
42. Gerdes LA, Klausen IB, Sihm I, Færgeman O. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol 1992;9:155-167.
43. Panza F, D'Introno A, Capurso C, Colacicco AM, Seripa D, Pilotto A, Santamato A, Capurso A, Solfrizzi V. Lipoproteins, vascular-related genetic factors, and human longevity. Rejuvenation Res 2007;10:441-458.
44. Olichney JM, Sabbagh MN, Hofstetter CR, Galasko D, Grundman M, Katzman R, Thal LJ. The impact of apolipoprotein E4 on cause of death in Alzheimer's disease. Neurology 1997;49:76-81. (Pubitemid 27328685)
45. Ewbank DC. Mortality differences by APOE genotype estimated from demographic synthesis. Genet Epidemiol 2002; 22:146-155. (Pubitemid 34081488)
46. Koivisto AM, Lempiäinen P, Koivisto K, Helkala EL, Mykka ̈nen L, Kuusisto J, Kervinen K, Kesäniemi YA, Laakso M, Soininen H. Apolipoprotein E phenotype alone does not influence survival in Alzheimer's disease: A population-based longitudinal study. Neuroepidemiology 2000;19:327-332.
47. Mahley RW. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-630.